Global hopes of vanquishing the coronavirus pandemic were boosted Monday after a vaccine was found to be nearly 95 percent effective in a trial, bringing much-needed optimism amid surging infections and grueling new restrictions.
Nov 16, 2020
0
7
A second experimental COVID-19 vaccine—this one from Moderna Inc.—yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase.
Nov 16, 2020
0
17
Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.
Nov 12, 2020
0
4
Data indicating that a vaccine being developed against COVID-19 is highly effective is the "best science news of the year", a pharmaceutical industry association chief said, voicing hope that other vaccine candidates would ...
Nov 12, 2020
0
0
Researchers led by Raghavan Varadarajan, professor at the Molecular Biophysics Unit, Indian Institute of Science (IISc), are working toward developing effective vaccine strategies against two viruses: SARS-CoV-2 and HIV.
Nov 11, 2020
0
17
A new global assessment of purchasing agreements for COVID-19 vaccines reveals that high-income countries, as well as a few middle-income countries flush with manufacturing capacity, have already purchased nearly 3.8 billion ...
Nov 11, 2020
0
4
Reports that one of the vaccines for COVID-19 has shown highly promising results are a ray of hope for a world in the shadow of surging virus cases.
Nov 10, 2020
0
1
A leading scientific adviser to the British government said Tuesday he expects several coronavirus vaccines to have been approved by early 2021, allowing life to begin to return to normal.
Nov 10, 2020
0
2
The United States on Tuesday registered a record 200,000 new COVID-19 cases in one day, highlighting the desperate need for a vaccine after results from one medical trial fuelled optimism around the world.
Nov 10, 2020
0
0
Key events in the development of a COVID-19 vaccine by partners Pfizer Inc. and Germany's BioNTech:
Nov 10, 2020
0
2
